Weekly Update: New diabetes clinical trial (17 items)

New diabetes clinical trial: Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring Published on: September 22, 2020 at 07:00PM Condition:   Coronary Atherosclerosis Intervention:   Device: continuous glucose monitoring (CGM) Sponsor:   National Cerebral and Cardiovascular Center Recruiting https://clinicaltrials.gov/ct2/show/NCT04559191?term=diabetes&sfpd_d=14 September 22, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Tricuspid Cardiopulmonary Exercise Study Published on: September 22, 2020 at 07:00PM Condition:   Tricuspid Regurgitation Intervention:   Diagnostic Test: Cardiopulmonary Exercise Testing Sponsor:   Heart and Diabetes Center North-Rhine Westfalia Recruiting https://clinicaltrials.gov/ct2/show/NCT04559256?term=diabetes&sfpd_d=14 September 22, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Low-Carb/Time-restricted Feeding Protocol in Insulin-Using Type 2 Diabetics Published on: September 22, 2020 at 07:00PM Condition:   Type2 Diabetes Interventions:   Other: Low Carbohydrate Diet;   Other: Time Restricted Feeding Sponsor:   University of Wisconsin, Madison Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04558827?term=diabetes&sfpd_d=14 September 22, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: The Effect of Frequent Continuous Glucose Monitoring Use on Glucose Variability in Preschoolers With Type 1 Diabetes Published on: September 22, 2020 at 07:00PM Conditions:   Type 1 Diabetes;   Continuous Glucose Monitoring;   Children;   Glucose Variability Intervention:   Sponsors:   University of Ljubljana, Faculty of Medicine;   International Society for Pediatric and Adolescent Diabetes;   Kinderkrankenhaus auf der Bult, Hannover, Germany;   Department of Pediatrcs, Endocrinology and Diabetes Medical University of Silesia in Katowice, Poland;   Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital of Verona, Verona, Italy;   Yale University School of Medicine, Department of Pediatrics, New Haven, Connecticut, United States;   Pediatric Endocrinology Unit, Paediatrics Department, Maternal and Paediatrics Centre, São João University and Hospital Centre, Porto, Porto, Portugal;   Department of Pediatrics, Section on Diabetes and Metabolism, V. Buzzi Children's Hospital, University of Milan, Milan, Italy;   Pediatric Endocrinology Unit. Hospital Pediátrico. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal;   Diaboss, Amsterdam, Netherlands;   Medical School, University of Valparaiso, San Felipe, Chile.;   Department of Pediatric Endocrinology and Diabetes, Koç University Hospital, İstanbul, Turkey.;   Department of Pediatrics, Sapienza University of Rome, Rome, Italy;   Department of Pediatrics, San Raffaele Scientific Institute , Milan, Italy Completed https://clinicaltrials.gov/ct2/show/NCT04558710?term=diabetes&sfpd_d=14 September 22, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Evaluation of Physical Activity and Quality of Life of Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic Published on: September 22, 2020 at 07:00PM Conditions:   Type 1 Diabetes Mellitus;   Covid19 Intervention:   Other: Online Survey Sponsor:   Gazi University Recruiting https://clinicaltrials.gov/ct2/show/NCT04558645?term=diabetes&sfpd_d=14 September 22, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Nurse-Led E-Health Program for Community-Dwelling Older Adults Living With Chronic Diseases Published on: September 23, 2020 at 07:00PM Conditions:   Diabetes Mellitus;   Hypertension;   Hyperlipidemias Interventions:   Behavioral: Nurse-led e-Health program;   Behavioral: usual self-management and follow up with doctors/nurse Sponsors:   National University, Singapore;   Changi General Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04560296?term=diabetes&sfpd_d=14 September 23, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors Published on: September 23, 2020 at 07:00PM Conditions:   Anatomic Stage I Breast Cancer AJCC v8;   Anatomic Stage IA Breast Cancer AJCC v8;   Anatomic Stage IB Breast Cancer AJCC v8;   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage IIA Breast Cancer AJCC v8;   Anatomic Stage IIB Breast Cancer AJCC v8;   Anatomic Stage III Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Anatomic Stage IIIB Breast Cancer AJCC v8;   Anatomic Stage IIIC Breast Cancer AJCC v8;   Early-Stage Breast Carcinoma;   Prognostic Stage I Breast Cancer AJCC v8;   Prognostic Stage IA Breast Cancer AJCC v8;   Prognostic Stage IB Breast Cancer AJCC v8;   Prognostic Stage II Breast Cancer AJCC v8;   Prognostic Stage IIA Breast Cancer AJCC v8;   Prognostic Stage IIB Breast Cancer AJCC v8;   Prognostic Stage III Breast Cancer AJCC v8;   Prognostic Stage IIIA Breast Cancer AJCC v8;   Prognostic Stage IIIB Breast Cancer AJCC v8;   Prognostic Stage IIIC Breast Cancer AJCC v8 Intervention:   Dietary Supplement: Dietary Intervention Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04560439?term=diabetes&sfpd_d=14 September 23, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes Published on: September 23, 2020 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Peripheral Arterial Disease Interventions:   Drug: Semaglutide;   Drug: Placebo (semaglutide) Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04560998?term=diabetes&sfpd_d=14 September 23, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice Published on: September 23, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Drug: Oral Semaglutide Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04559815?term=diabetes&sfpd_d=14 September 23, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Contextualizing the Evidence for Action on Diabetes - Cohort Published on: September 23, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Other: Spontaneous changes in diabetes-related health care Sponsors:   Universidad Miguel Hernandez de Elche;   European Research Council;   Pontificia Universidad Católica del Ecuador;   Centro de Epidemiología Comunitaria y Medicina Tropical Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04560062?term=diabetes&sfpd_d=14 September 23, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: An Exploratory Study on the Application of Continuous Glucose Monitoring System in the Measurement of Individual Glycemic Index After Eating Different Diets Published on: September 24, 2020 at 07:00PM Condition:   Diabetes Intervention:   Other: Specific diet Sponsor:   Peking Union Medical College Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04562454?term=diabetes&sfpd_d=14 September 24, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: The Effects of an Intensive Lifestyle Intervention on Employment, Earnings, and Retirement Published on: September 24, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Behavioral: Intensive lifestyle intervention (ILI);   Behavioral: Diabetes support and education (DSE) Sponsors:   University of Minnesota;   University of Southern California;   Wake Forest University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT04563598?term=diabetes&sfpd_d=14 September 24, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy Published on: September 24, 2020 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Glucose Interventions:   Device: FreeStyle Libre Flash Glucose Monitor;   Other: Diabetes self-management education Sponsors:   LMC Diabetes & Endocrinology Ltd.;   Abbott Diabetes Care Recruiting https://clinicaltrials.gov/ct2/show/NCT04562714?term=diabetes&sfpd_d=14 September 24, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins Published on: September 25, 2020 at 07:00PM Conditions:   Type2 Diabetes;   NAFLD Intervention:   Dietary Supplement: protein supplement Sponsor:   Charite University, Berlin, Germany Recruiting https://clinicaltrials.gov/ct2/show/NCT04564391?term=diabetes&sfpd_d=14 September 25, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: GLucose Monitoring Programme SingaporE, Phase 2 (GLiMPSE2) Published on: September 25, 2020 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Flash Glucose Monitoring Interventions:   Combination Product: Flash Glucose Monitoring and Education;   Combination Product: Capillary glucose monitoring and Education Sponsors:   Singapore General Hospital;   National University Hospital, Singapore;   SingHealth Polyclinics;   National Healthcare Group Polyclinics;   National University Polyclinics, Singapore Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04564911?term=diabetes&sfpd_d=14 September 25, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: A Phase 2b Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus Published on: September 25, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: ORMD-0801;   Other: Placebo Sponsor:   Oramed, Ltd. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04564846?term=diabetes&sfpd_d=14 September 25, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus Published on: September 25, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: HSK7653 10 mg Q2W;   Drug: HSK7653 25 mg Q2W;   Drug: Linagliptin 5 mg QD Sponsor:   Sichuan Haisco Pharmaceutical Group Co., Ltd. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04564872?term=diabetes&sfpd_d=14 September 25, 2020 at 02:24PM via ClinicalTrials.gov